generics
-
News
SNAMI. NO to therapeutic equivalence of drugs. Not everything is allowed in the name of savings
Roma, 5 Giugno 2018-Critiche pesanti del sindacato Snami all’emanazione da parte dell’AIFA dei criteri per determinare l’equivalenza terapeutica tra due…
Leggi » -
News
Rheumatic patients association. Biosimilars yes, but the patient's health must come before the budget
Biosimilars in rheumatic patients: Anmar's position The National Association of Rheumatic Patients anticipates the contents of a position paper which…
Leggi » -
News
Astrazeneca pays for the advance of generics
The collapse of profits ballast Astrazeneca, which fell sharply on the London Stock Exchange with -2.71% to 5.2 euros. There…
Leggi » -
News
The Chinese pharmaceutical market ranks second in the world after the United States
According to data recently collected by the health information company IQVIA, China has reached the second position as the…
Leggi » -
News
generics. Veneto TAR agrees with the Region "for technical reasons"
REJECTED BY VENETO TAR APPEAL AGAINST VENETO REGION AND ZERO COMPANY FOR AWARD OF EQUIVALENT DRUG FOR HIV TREATMENT "The failure…
Leggi » -
News
Piedmont, Cossolo (Federfarma) on medicines by bike at home: "Under these conditions"
Piedmont, Cossolo on medicines by bike at home: "Under these conditions" 12/04/2018 - Federfarma Federfarma takes action on the case of…
Leggi » -
News
China launches package of rules to protect generic drugs
The Chinese government has issued a new package of provisions, including tax breaks, to promote generic medicines. The whole…
Leggi » -
First floor
EMA recommends the suspension of 300 generics. Unreliable
EMA recommends suspension of drugs due to unreliable studies by Micro Therapeutic Research Labs The drugs in…
Leggi » -
News
Häusermann (Assogenerici): “Grateful to the pharmacists for spreading the culture of generics”. Ed
The equivalent drug industry recognizes a great merit to pharmacies, namely that of having 'educated' the…
Leggi » -
News
Assogenerics. "Pure" generics absorb 21.5% in units and 12.4% in pharmacy channel values
Another year of growth for the generic drug market which in 2017 absorbed 21.5% per pack…
Leggi »